中国实用医刊
中國實用醫刊
중국실용의간
CENTRAL PLAINS MEDICAL JOURNAL
2010年
21期
25-26,29
,共3页
路培发%孔令贵%杜宝青%方志勇%王斌
路培髮%孔令貴%杜寶青%方誌勇%王斌
로배발%공령귀%두보청%방지용%왕빈
食管肿瘤%食管次全切除%吻合术%外科
食管腫瘤%食管次全切除%吻閤術%外科
식관종류%식관차전절제%문합술%외과
Esophageal neoplasm%Subtotal esophagectomy%Anastomosis%Surgical
目的 总结食管癌行食管次全切除胃代食管颈部吻合术的临床经验.方法 回顾性分析132例胸段食管癌手术患者,所有患者均采用食管次全切除胃代食管经食管床颈部吻合术式.结果 全组无围术期死亡患者,无切缘癌阳性.吻合口瘘4例(3.0%),吻合口狭窄5例(3.8%),喉返神经损伤3例(2.3%).103例获随访,所有患者术后生活质量满意,无明显胃食管返流的症状;3、5年生存率分别是78.5%、34.6%.结论 食管次全切除食管纵膈胃颈部吻合术能显著降低食管癌患者围术期病死率和并发症发生率,是治疗食管癌的一种安全有效的手术方式.
目的 總結食管癌行食管次全切除胃代食管頸部吻閤術的臨床經驗.方法 迴顧性分析132例胸段食管癌手術患者,所有患者均採用食管次全切除胃代食管經食管床頸部吻閤術式.結果 全組無圍術期死亡患者,無切緣癌暘性.吻閤口瘺4例(3.0%),吻閤口狹窄5例(3.8%),喉返神經損傷3例(2.3%).103例穫隨訪,所有患者術後生活質量滿意,無明顯胃食管返流的癥狀;3、5年生存率分彆是78.5%、34.6%.結論 食管次全切除食管縱膈胃頸部吻閤術能顯著降低食管癌患者圍術期病死率和併髮癥髮生率,是治療食管癌的一種安全有效的手術方式.
목적 총결식관암행식관차전절제위대식관경부문합술적림상경험.방법 회고성분석132례흉단식관암수술환자,소유환자균채용식관차전절제위대식관경식관상경부문합술식.결과 전조무위술기사망환자,무절연암양성.문합구루4례(3.0%),문합구협착5례(3.8%),후반신경손상3례(2.3%).103례획수방,소유환자술후생활질량만의,무명현위식관반류적증상;3、5년생존솔분별시78.5%、34.6%.결론 식관차전절제식관종격위경부문합술능현저강저식관암환자위술기병사솔화병발증발생솔,시치료식관암적일충안전유효적수술방식.
Objective To conclude the clinical experience of subtotal esophagectomy and cervical gastroesophagostomy for the treatment of esophageal carcinoma. Methods One hundred and thirty-two patients with esophageal carcinoma of thoracic part who underwent surgical treatment were analyzed retrospectively.All patients were given subtotal esophageal resection and cervical gastroesophagostomy. Results There were no perioperative mortality,no edge-residual cancer,no postoperative gastroesophageal reflux in all patients.Complications included:cervical anastomotic leakage of 4 cases(3.0%);anastomotic stenosis of 5 (3.8%); larygeal nerve injury of 3 (2.3%).One hurdred and three patients who were followed up showed normal and satisfied life quality.The 3-year,5-year survival rate were 78 5%,34.6%, respectively. Conclusions Cervical gastroesophagostomy after subtotal esophagectomy can decrease peioperative mortality and incidence of complications and can be used as a safe and effective surgical procedure for the treatment of esophageal carcinoma.